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Abstract
Phosphatidylinositol 4-kinases (PI4Ks) and small guanosine triphosphatases (GTPases) are
essential for processes that require expansion and remodeling of phosphatidylinositol 4-phosphate
(PI4P)-containing membranes, including cytokinesis, intracellular development of malarial
pathogens, and replication of a wide range of RNA viruses. However, the structural basis for
coordination of PI4K, GTPases and their effectors is unknown. Here, we describe structures of
PI4KB (PI4KIIIβ) bound to the small GTPase Rab11a without and with the Rab11 effector protein
FIP3. The Rab11-PI4KIIIβ interface is unique compared with known structures of Rab complexes,
and does not involve switch regions used by GTPase effectors. Our data provide a mechanism for
how PI4KIIIβ coordinates Rab11 and its effectors on PI4P-enriched membranes, and also provide
strategies for the design of specific inhibitors that could potentially target plasmodial PI4KIIIβ to
combat malaria.
Intracellular compartments are essential to eukaryotic cell biology, and both small GTPases
and lipids such as phosphoinositides are key components of compartment identity (1, 2). The
phosphatidylinositol 4-kinases (PI4Ks) and the small G-protein Rab11 play prominent roles
in compartment identity. PI4KIIIβ is one of four mammalian PI4K enzymes that
phosphorylate phosphatidylinositol to generate phosphatidylinositol 4-phosphate (PI4P).
PI4KIIIβ localizes primarily at the Golgi and is essential for Golgi formation and function
(3-5). PI4P is recognized by protein modules including the PH domains of oxysterol-binding
protein (OSBP), ceramide transfer protein (CERT) and four-phosphate-adaptor protein
(FAPP) that are important for intra-Golgi transport (6-8). However, typically, lipid
recognition alone is not sufficient for Golgi localization, which requires both PI4P and
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specific small GTPases. In addition to its catalytic role in synthesizing PI4P, PI4KIIIβ also
has non-catalytic roles that rely on the interactions with other proteins such as the small
GTPase Rab11 (9). Rab11 is predominately located on recycling endosomes (10). However,
Rab11 is also found associated with Golgi membranes, which requires an interaction with
PI4KIIIβ (9).
PI4KIIIβ activity is essential for replication of a range of RNA viruses, including
enteroviruses, SARS coronavirus and hepatitis C virus (11, 12). These RNA viruses hijack
the activity of host cell PI4KIIIβ to generate replication organelles enriched in PI4P. There
is no approved anti-viral therapy for enteroviruses. However, several compounds inhibit
enteroviral replication by targeting cellular PI4KIIIβ (13, 14). PI4KIIIβ is also important in
malaria, and inhibitors of Plasmodium falciparum PI4KIIIβ are potent anti-malarial agents.
However, mutations in both PI4KIIIβ and Rab11 confer resistance to these compounds (15).
Inhibition of the P. falciparum PI4KIIIβ prevents the membrane ingression that occurs
during completion of the asexual erythrocytic stage of the plasmodial lifecycle. The role of
Plasmodium Rab11 and PI4KIIIβ in membrane remodeling is similar to the role of Rab11
and PI4KIIIβ in cytokinesis in Drosophila spermactocytes (16). In Drosophila, PI4KIIIβ is
required for the recruitment of both Rab11 and its downstream effectors.
To understand how PI4KIIIβ can both recruit Rab11 and enable its interactions with Rab11
effectors, we used a hydrogen deuterium exchange mass spectrometry (HDX-MS) to
facilitate the x-ray crystal structure determination of human PI4KIIIβ in complex with
Rab11a-GTPγS at 2.9 Å resolution (see supplementary materials and methods). To form
crystals, highly flexible regions of PI4KIIIβ identified by HDX-MS were truncated (residues
1-120, 408-507, and 785-801, Fig. 1A). This included a C-terminal region necessary for
catalytic activity (fig. S2A). The PI4KIIIβ structure consists of two domains, a right-handed
helical solenoid (residues 128-243) and a kinase domain (residues 306-801) (Fig. 1B) that
are related to the PI3Ks (fig. S3). The kinase domain has two lobes, an N-terminal lobe
dominated by a five-stranded anti-parallel β-sheet and a C-terminal lobe that is largely
helical, with the ATP-binding site located in a cleft between the lobes. The N-lobe of
PI4KIIIβ has a PI4KIIIβ-unique, large insertion (residues 391-539) (Fig. 1B).
PI4KIIIβ makes a unique interaction with Rab11a that is not characteristic of any Rab or Arf
effector (17). This interaction involves primarily helix α3 of the PI4KIIIβ helical domain
(Fig. 1B and 2A). Because a previous study of human PI4KIIIβ mapped the epitope
interacting with Rab11a to the insertion in the N-lobe of the kinase domain (9), we also used
HDX-MS to determine the Rab11 binding site on full-length PI4KIIIβ in solution (figs. S4
and S5). The HDX-MS measurements confirmed the interaction between the N-terminal part
of the PI4KIIIβ helical domain and Rab11a (Fig. S5). Soluble Rab11 had no effect on
PI4KIIIβ activity (fig. S2B).
The PI4KIIIβ-Rab11 interface is predominately hydrophobic with no hydrogen bonds or salt
links (Fig. 2A). Surprisingly, PI4KIIIβ makes only a single, peripheral contact with the
Rab11 switch I (only with the edge residues 38-LES-40 of switch I) and no contact with
switch II (Fig. 2A and B). The “switch” regions change conformation depending on whether
Rab11 is bound to GTP or GDP. Consistent with the structure, PI4KIIIβ bound both GTP-
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and GDP-loaded Rab11, with a slight preference for GTP (Fig. 2D and fig. S6). Within the
PI4KIIIβ-Rab11 interface, G155 (18) of PI4KIIIβ makes a direct contact with the ribose
moiety of GTPγS bound to the Rab11 (Fig. 2A). The small residue at position 155 is
completely conserved among PI4KIIIβ homologs, from yeast to mammals, and might be
required to maintain the contact with Rab11. Indeed, a PI4KIIIβ-G155D mutation decreased
binding to Rab11 (Fig. 2C and D). Consistent with PI4KIIIβ directly contacting the
nucleotide, PI4KIIIβ decreased the rate of EDTA-mediated Rab11 nucleotide exchange (Fig.
S2C). PI4KIIIβ residues Y159, N162 and F165 also form prominent contacts with the
Rab11. The mutants PI4KIIIβ-Y159A, N162A, F165A and the double mutant Y159A/
N162A all eliminated measurable binding to Rab11 (Fig. 2C and D). The Rab11 residues
interacting with PI4KIIIβ are all conserved among Rab11a and Rab11b, but not among other
Rabs that do not bind PI4KIIIβ (Fig. 2B). The PI4KIIIβ residues interacting with Rab11 are
also strongly conserved among PI4KIIIβ orthologs (Fig. 2B, fig. S3).
The structure of the PI4KIIIβ-Rab11a complex shows that the Rab11a switch regions
remained available to contact Rab11a effectors. Among the Rab11 effectors is a family of
related proteins known as the Rab11 family interacting proteins or FIPs (19). In Drosophila,
both catalytic and non-catalytic functions of Four wheel drive (PI4KIIIβ ortholog in
Drosophila) are required for the proper localization of both Rab11a and its downstream
effector Nuf (ortholog of human FIP3) at the cleavage furrow, which is essential for
cytokinesis in spermatocytes (16). During interphase, FIP3 is required for the structural
integrity of the pericentriolar recycling endosome compartment (20), whereas during
cytokinesis it is involved in delivering material from recycling endosomes to the cleavage
furrow (21). The FIP proteins interact with Rab11 using a conserved C-terminal region
known as the Rab-binding domain (RBD). Two FIPs form a parallel coiled-coil dimer with
two Rab11 binding sites (22-24) that engage both switch I and switch II of Rab11.
The structure of Rab11a bound to the RBD domain of FIP3 (22-24) and our structure of the
PI4KIIIβ-Rab11a complex suggest that a ternary complex might be formed. Indeed, GST
pulldowns carried out with the GST-tagged RBD domain from FIP3 (residues 713-756)
revealed that the complex of the FIP3-RBD with GTPγS-loaded Rab11a (Q70L) was able to
bind PI4KIIIβ (Fig. 3A). To understand how this occurs, we crystallized a ternary PI4KIIIβ/
Rab11a/FIP3-RBD complex. Although this is a low-resolution (6 Å) structure with a very
large asymmetric unit (~ 1 MDa, containing 12 ternary complexes), both FIP3 and PI4KIIIβ
were bound simultaneously to Rab11a-GTPγS (Fig. 3B, fig. S7). The ability of PI4KIIIβ to
recruit both Rab11a and its downstream effectors is unlikely to be limited to only the FIP
family of proteins. The production of PI4P by Pik1, the yeast ortholog of PI4KIIIβ, is
required for the Ypt32 (yeast ortholog of Rab11) dependent recruitment of the Rab guanine
nucleotide-exchange factor Sec2 (25), in a phosphoinositide-dependent regulation of Rab
activation cascade. The conservation of the PI4KIIIβ-Rab11a interface in Pik1 and Ypt32
indicates the possibility of a ternary Pik1-Ypt32-Sec2 complex. Furthermore, the switch-
independent interaction of PI4KIIIβ with Rab11 suggests that ternary PI4KIIIβ/Rab11/
RabGAP and PI4KIIIβ/Rab11/Rab Escort complexes could also be formed (fig. S8).
The inhibitor PIK93 shows a clear selectivity for PI4KIIIβ over PI4KIIIα, with partial
selectivity over PI3Ks (26). This inhibitor has been used to decipher PI4K-specific functions
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(27), for example in demonstrating the role of PI4KIIIβ in viral replication (11). PIK93
bound in the ATP-binding pocket, using its thiazol and acetamide moieties to make a pair of
hydrogen bonds with the backbone of V598 in the hinge between the N- and C-lobes (Fig.
4A, fig. S9A). The PI4KIIIβ ATP-binding pocket and those of PI3Ks and
phosphatidylinositol 3-kinase-related kinases (PIKKs) show considerable consistency. Most
of the contacts that PIK93 makes with PI4KIIIβ involve residues that are conserved among
both the PI3Ks and PI4Ks (Fig. 4A and C). The PIK93 sulfamoyl moiety makes a hydrogen
bond with K549 of PI4KIIIβ. Although this lysine is conserved in the PI3Ks, its
conformation is variable and in the structures of PIK93 in complex with either p110γ (26) or
Vps34 (28), the equivalent lysine does not make this hydrogen bond (fig. S9B). There is
more sequence divergence in the residues near the hinge. Though the class III PI3K Vps34
is more closely related to PI4KIIIβ than other PI3Ks, PIK93 is a poor inhibitor of Vps34.
The PI4KIIIβ has a great deal of space near the hinge that allows PIK93 to form hydrogen
bonds with the hinge and simultaneously optimize contacts elsewhere (fig. S9B). Y583
packs against the hinge to form one wall of the pocket contacting both the Cl substituent of
the thiazole and the phenyl moiety. The structure helps rationalize why a Y583M mutation
makes PI4KIIIβ insensitive to wortmannin and PIK93 (29) (fig. S9C).
Inhibitors specific against plasmodial PI4KIIIβ are potent anti-malarial agents and resistance
mutations in either Rab11a or PI4KIIIβ can evade the anti-malarial activity of these
compounds (15). The plasmodial Y1356F resistance mutation involves the hinge residue,
which is equivalent to human P597. It may be that Y1356 makes an additional interaction
with the inhibitor (Fig. 4B and D). The S1320L resistance mutation corresponds to F561 in
human PI4KIIIβ. This residue packs against Y583 (Y1342 in P. falciparum), which forms
one wall of the inhibitor-binding pocket, and the mutation may alter the conformation of the
pocket. The third mutation, H1484Y is in a bend between kα8 and kα9 and is equivalent to
H728 in human PI4KIIIβ. Several somatic mutations associated with cancer have been
detected for human p110α PI3K in the equivalent bend, and the most common of these
mutations increases enzymatic activity and membrane binding (30). It is plausible that the
H1484Y resistance mutation is making PI4KIIIβ more active.
The structures of a binary complex of PI4KIIIβ with Rab11a and a ternary complex of
PI4KIIIβ with Rab11a and Rab11-effector FIP3 revealed a novel Rab11 interface that is
compatible with the PI4KIIIβ-driven recruitment of Rab11 and its effectors to PI4P-enriched
membranes. PI4KIIIβ plays key roles in regulating Rab11a in cytokinesis of spermatocytes,
recruitment of Rab-guanine nucleotide exchange factors in yeast, and membrane remodeling
in Plasmodium development. The PI4KIIIβ-Rab11 interface is conserved and demonstrates
that PI4K, in addition to its kinase activity, plays key kinase-independent roles in mediating
these membrane trafficking events. This structure opens up exciting prospects for the
development of highly specific inhibitors, which may act as potent anti-malarial and anti-
viral therapeutics.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Crystal structure of human PI4KIIIβ complex with Rab11a(Q70L)-GTPγS
(A) Full-length PI4KIIIβ (isoform 2) (left) and constructs of PI4KIIIβ and Rab11a(Q70L)
used for crystallization (right). The PI4KIIIβ crystallization construct contained three
deletions as well as an S294A mutation. (B) Overall architecture of the complex. The PI4K-
specific insertion (residues 391-540) in the N-lobe is salmon colored. The large spheres
mark a disordered region within which residues 408-507 are deleted. The switch I and
switch II regions of Rab11a(Q70L) are represented in orange.
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Fig. 2. The PI4KIIIβ/Rab11a interface
(A) Close-up view of the PI4KIIIβ/Rab11a interface. (B) Sequence alignment of interacting
regions in Rabs and PI4KIIIβs. Conserved and similar residues are highlighted (red shading
and red letters, respectively). Rab11a residues that interact with PI4KIIIβ are indicated with
green arrowheads; light blue arrowheads denote PI4KIIIβ residues interacting with Rab11.
Rab sequences are grouped into Rabs previously shown to either bind PI4KIIIβ (binders) or
not bind PI4KIIIβ (non-binders). (C) Pull-down assays with GST-tagged Rab11A(Q70L)-
GTPγS and either wild-type or mutant full-length PI4KIIIβ. The inputs and the bound
proteins (lanes 1 and 2, respectively) were analysed on SDS gels stained with InstantBlue.
(D) Surface plasmon resonance (SPR) analysis of the full length wild-type PI4KIIIβ binding
to the immobilized GST-tagged Rab11a(Q70L) loaded with either GDP (red sensogram) or
GTPγS (blue). The affinity of PI4KIIIβ for GST-Rab11a is indicated next to the graphs (data
are mean +/− SEM based on five independent experiments). Full details are shown in Fig.
S6. Also shown are the sensograms for several PI4KIIIβ mutants binding to Rab11a(Q70L)-
GTPγS.
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Fig. 3. Ternary complex of PI4KIIIβ with Rab11a-GTP and effector protein FIP3
(A) Pulldown assays with GST-tagged-FIP3 fragment (residues 713-756) and full length
PI4KIIIβ either with or without Rab11a(Q70L)-GTPγS. The inputs and the bound proteins
were analyzed on SDS gels stained with InstantBlue. (B) Crystal structure of the ternary
complex of PI4KIIIβ, Rab11a-GTPγS and the FIP3 RBD domain.
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Fig. 4. Inhibitor binding to PI4KIIIβ
(A) Interactions of PI4KIIIβ with PIK93. Dotted lines represent putative hydrogen bonds
(prepared by LIGPLOT (31)). For each PI4KIIIβ residue, the equivalent residues are shown
below for human Vps34, human mTOR, human p110α and P. falciparum PI4KIIIβ (left to
right). (B) Ribbon diagram of PI4KIIIβ illustrating sites of P. falciparum resistance
mutations (spheres). The helical domain is colored from dark to light blue from N-terminus
to the C-terminus. (C) PIK93 bound to PI4KIIIβ. (D) Close-up of the active site, illustrating
positions of P. falciparum resistance mutations.
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